Missing and possible link between neuroendocrine factors, neuropsychiatric disorders and microglia

Frontiers in Integrative Neuroscience

Volumn , Issue JUL, 2013, Pages

  Kato, Takahiro A ^a,b   Hayakawa, Kohei ^a   Monji, Akira ^c   Kanba, Shigenobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing hormone (CRH); Endocrinology; Estradiol; Glucocorticoids; Microglia; Oxytocin; Sex hormones

Indexed keywords

ANDROSTENEDIONE; BENZODIAZEPINE RECEPTOR; CD38 ANTIGEN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; ESTRADIOL; ESTRIOL; ESTROGEN; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 18; INTERLEUKIN 6; MINOCYCLINE; OXYTOCIN; OXYTOCIN DERIVATIVE; PRASTERONE; PREGNENOLONE; PROGESTERONE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; SIGMA 1 OPIATE RECEPTOR; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY DISORDER; ARTICLE; AUTISM; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL ACTIVITY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DYSPHORIA; ENZYME ACTIVATION; ENZYME RELEASE; ESTRADIOL BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; IRRITABILITY; MENOPAUSE; MENSTRUAL CYCLE; MENTAL DISEASE; MICROGLIA; MOOD DISORDER; NERVE CELL NETWORK; NEUROENDOCRINE SYSTEM; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PUERPERIUM; RETT SYNDROME; SCHIZOPHRENIA; SEX DIFFERENCE; SUICIDE; TESTOSTERONE BLOOD LEVEL;

EID: 84879768071     PISSN: 16625145     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnint.2013.00053     Document Type: Article

References (239)

1. (2005). NIH State-of-the-Science Conference Statement on management of menopause-related symptoms. NIH Consens State Sci Statements 22, 1-38.
2. Ahokas, A., Aito, M., and Rimon, R. (2000). Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 61, 166-169.
3. Alonso, A., Jick, S.S., Olek, M.J., Ascherio, A., Jick, H., and Hernan, M.A. (2005). Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62, 1362-1365.
4. Amir, R.E., Van Den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., and Zoghbi, H.Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185-188.
5. Andari, E., Duhamel, J.R., Zalla, T., Herbrecht, E., Leboyer, M., and Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A 107, 4389-4394.
6. Baischer, W., Koinig, G., Hartmann, B., Huber, J., and Langer, G. (1995). Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 20, 553-559.
7. Baker, D.G., West, S.A., Nicholson, W.E., Ekhator, N.N., Kasckow, J.W., Hill, K.K., Bruce, A.B., Orth, D.N., and Geracioti, T.D., Jr. (1999). Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156, 585-588.
8. Barreto, G., Veiga, S., Azcoitia, I., Garcia-Segura, L.M., and Garcia-Ovejero, D. (2007). Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur J Neurosci 25, 3039-3046.
9. Batra, N.A., Seres-Mailo, J., Hanstock, C., Seres, P., Khudabux, J., Bellavance, F., Baker, G., Allen, P., Tibbo, P., Hui, E., and Le Melledo, J.M. (2008). Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry 63, 1178-1184.
10. Ben-Jonathan, N., and Hnasko, R. (2001). Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22, 724-763.
11. Bloch, M., Daly, R.C., and Rubinow, D.R. (2003). Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 44, 234-246.
12. Bloch, M., Rubinow, D.R., Schmidt, P.J., Lotsikas, A., Chrousos, G.P., and Cizza, G. (2005). Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. J Clin Endocrinol Metab 90, 695-699.
13. Bloch, M., Schmidt, P.J., Danaceau, M., Murphy, J., Nieman, L., and Rubinow, D.R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157, 924-930.
14. Block, M.L., Zecca, L., and Hong, J.S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8, 57-69.
15. Brinton, R.D., Thompson, R.F., Foy, M.R., Baudry, M., Wang, J., Finch, C.E., Morgan, T.E., Pike, C.J., Mack, W.J., Stanczyk, F.Z., and Nilsen, J. (2008). Progesterone receptors: form and function in brain. Front Neuroendocrinol 29, 313-339.
16. Brockington, I.F., Cernik, K.F., Schofield, E.M., Downing, A.R., Francis, A.F., and Keelan, C. (1981). Puerperal Psychosis. Phenomena and diagnosis. Arch Gen Psychiatry 38, 829-833.
17. Bromberger, J.T., Kravitz, H.M., Chang, Y.F., Cyranowski, J.M., Brown, C., and Matthews, K.A. (2011). Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 41, 1879-1888.
18. Bromberger, J.T., Kravitz, H.M., Matthews, K., Youk, A., Brown, C., and Feng, W. (2009). Predictors of first lifetime episodes of major depression in midlife women. Psychol Med 39, 55-64.
19. Brown, E.S. (2009). Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179, 41-55.
20. Brown, J., Pm, O.B., Marjoribanks, J., and Wyatt, K. (2009). Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev, CD001396.
21. Bruce-Keller, A.J., Keeling, J.L., Keller, J.N., Huang, F.F., Camondola, S., and Mattson, M.P. (2000). Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141, 3646-3656.
22. Brugha, T.S., Mcmanus, S., Bankart, J., Scott, F., Purdon, S., Smith, J., Bebbington, P., Jenkins, R., and Meltzer, H. (2011). Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 68, 459-465.
23. Busillo, J.M., Azzam, K.M., and Cidlowski, J.A. (2011). Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem 286, 38703-38713.
24. Capuron, L., Raison, C.L., Musselman, D.L., Lawson, D.H., Nemeroff, C.B., and Miller, A.H. (2003). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160, 1342-1345.
25. Challis, J.R., Lockwood, C.J., Myatt, L., Norman, J.E., Strauss, J.F., 3rd, and Petraglia, F. (2009). Inflammation and pregnancy. Reprod Sci 16, 206-215.
26. Chandrasekar, G., Lauter, G., and Hauptmann, G. (2007). Distribution of corticotropin-releasing hormone in the developing zebrafish brain. J Comp Neurol 505, 337-351.
27. Chappell, P.B., Smith, M.A., Kilts, C.D., Bissette, G., Ritchie, J., Anderson, C., and Nemeroff, C.B. (1986). Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6, 2908-2914.
28. Chen, R.Z., Akbarian, S., Tudor, M., and Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27, 327-331.
29. Chrousos, G.P., and Gold, P.W. (1992). The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267, 1244-1252.
30. Confavreux, C., Hutchinson, M., Hours, M.M., Cortinovis-Tourniaire, P., and Moreau, T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339, 285-291.
31. Crain, J.M., Nikodemova, M., and Watters, J.J. (2009). Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia. J Neuroinflammation 6, 24.
32. De Pablos, R.M., Villaran, R.F., Arguelles, S., Herrera, A.J., Venero, J.L., Ayala, A., Cano, J., and Machado, A. (2006). Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 26, 5709-5719.
33. Del Rio-Hortega, P. (1919). El tercer elemento de los centros nerviosos. I. La microglia en estado normal. II. Intervencion de la microglia en los procesos patologicos. HI. Naturaleza probable de la microglia. Boll Socieded Esp biol 9, 69-120.
34. Derecki, N.C., Cronk, J.C., Lu, Z., Xu, E., Abbott, S.B., Guyenet, P.G., and Kipnis, J. (2012). Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109.
35. Dhingra, V., Magnay, J.L., O'brien, P.M., Chapman, G., Fryer, A.A., and Ismail, K.M. (2007). Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstet Gynecol 110, 788-792.
36. Dinkel, K., Macpherson, A., and Sapolsky, R.M. (2003). Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 84, 705-716.
37. Dodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Sixel-Doring, F., Herting, B., Kamm, C., Gasser, T., Sawires, M., Geser, F., Kollensperger, M., Seppi, K., Kloss, M., Krause, M., Daniels, C., Deuschl, G., Bottger, S., Naumann, M., Lipp, A., Gruber, D., Kupsch, A., Du, Y., Turkheimer, F., Brooks, D.J., Klockgether, T., Poewe, W., Wenning, G., Schade-Brittinger, C., Oertel, W.H., and Eggert, K. (2010). Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 25, 97-107.
38. Doorduin, J., De Vries, E.F., Willemsen, A.T., De Groot, J.C., Dierckx, R.A., and Klein, H.C. (2009). Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50, 1801-1807.
39. Du, Y., Ma, Z., Lin, S., Dodel, R.C., Gao, F., Bales, K.R., Triarhou, L.C., Chernet, E., Perry, K.W., Nelson, D.L., Luecke, S., Phebus, L.A., Bymaster, F.P., and Paul, S.M. (2001). Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98, 14669-14674.
40. Dunn, A.J., Swiergiel, A.H., and Palamarchouk, V. (2004). Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann N Y Acad Sci 1018, 25-34.
41. Duquette, P., Pleines, J., Girard, M., Charest, L., Senecal-Quevillon, M., and Masse, C. (1992). The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 19, 466-471.
42. Egli, M., Leeners, B., and Kruger, T.H. (2010). Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction 140, 643-654.
43. Epperson, C.N., Haga, K., Mason, G.F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D.L., and Krystal, J.H. (2002). Cortical gammaaminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59, 851-858.
44. Eser, D., Schule, C., Romeo, E., Baghai, T.C., Di Michele, F., Pasini, A., Zwanzger, P., Padberg, F., and Rupprecht, R. (2006). Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology (Berl) 186, 373-387.
45. Finkelsztejn, A., Brooks, J.B., Paschoal, F.M., Jr., and Fragoso, Y.D. (2011). What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118, 790-797.
46. Frank, M.G., Baratta, M.V., Sprunger, D.B., Watkins, L.R., and Maier, S.F. (2007). Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 21, 47-59.
47. Frank, M.G., Miguel, Z.D., Watkins, L.R., and Maier, S.F. (2010). Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav Immun 24, 19-30.
48. Frank, M.G., Thompson, B.M., Watkins, L.R., and Maier, S.F. (2012). Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun 26, 337-345.
49. Freeman, E.W., Sammel, M.D., Liu, L., Gracia, C.R., Nelson, D.B., and Hollander, L. (2004a). Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61, 62-70.
50. Freeman, E.W., Sammel, M.D., Rinaudo, P.J., and Sheng, L. (2004b). Premenstrual syndrome as a predictor of menopausal symptoms. Obstet Gynecol 103, 960-966.
51. Freeman, M.E., Kanyicska, B., Lerant, A., and Nagy, G. (2000). Prolactin: structure, function, and regulation of secretion. Physiol Rev 80, 1523-1631.
52. Freeman, M.P., Smith, K.W., Freeman, S.A., Mcelroy, S.L., Kmetz, G.E., Wright, R., and Keck, P.E., Jr. (2002). The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 63, 284-287.
53. George, M.S., Guidotti, A., Rubinow, D., Pan, B., Mikalauskas, K., and Post, R.M. (1994). CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry 35, 775-780.
54. Gonzalez-Rey, E., Ganea, D., and Delgado, M. (2010). Neuropeptides: keeping the balance between pathogen immunity and immune tolerance. Curr Opin Pharmacol 10, 473-481.
55. Gounko, N.V., Swinny, J.D., Kalicharan, D., Jafari, S., Corteen, N., Seifi, M., Bakels, R., and Van Der Want, J.J. (2013). Corticotropin-releasing factor and urocortin regulate spine and synapse formation: structural basis for stressinduced neuronal remodeling and pathology. Mol Psychiatry 18, 86-92.
56. Graeber, M.B. (2010). Changing face of microglia. Science 330, 783-788.
57. Graeber, M.B., and Christie, M.J. (2012). Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Exp Neurol 234, 255-261.
58. Graeber, M.B., and Streit, W.J. (2010). Microglia: biology and pathology. Acta Neuropathol 119, 89-105.
59. Gregoire, A.J., Kumar, R., Everitt, B., Henderson, A.F., and Studd, J.W. (1996). Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347, 930-933.
60. Hammarback, S., Backstrom, T., Holst, J., Von Schoultz, B., and Lyrenas, S. (1985). Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64, 393-397.
61. Hanisch, U.K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10, 1387-1394.
62. Harlow, B.L., Wise, L.A., Otto, M.W., Soares, C.N., and Cohen, L.S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60, 29-36.
63. Hashimoto, K. (2013). Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression. Prog Neurobiol 100, 15-29.
64. Hashimoto, K., and Ishima, T. (2010). A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI. PLoS One 5, e15430.
65. Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., Mcgeer, P.L., and Kanba, S. (2007). Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 206, 33-42.
66. Heinrichs, M., Baumgartner, T., Kirschbaum, C., and Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54, 1389-1398.
67. Hiroi, R., Mcdevitt, R.A., and Neumaier, J.F. (2006). Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry 60, 288-295.
68. Ho, H.P., Olsson, M., Westberg, L., Melke, J., and Eriksson, E. (2001). The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability? Neuropsychopharmacology 24, 502-510.
69. Hollander, E., Bartz, J., Chaplin, W., Phillips, A., Sumner, J., Soorya, L., Anagnostou, E., and Wasserman, S. (2007). Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61, 498-503.
70. Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
71. Horikawa, H., Kato, T.A., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., and Kanba, S. (2010). Inhibitory effects of SSRIs on IFN-gamma induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry 34, 1306-1316.
72. Inoue, K., and Tsuda, M. (2009). Microglia and neuropathic pain. Glia 57, 1469-1479.
73. Jack, C., Ruffini, F., Bar-Or, A., and Antel, J.P. (2005). Microglia and multiple sclerosis. J Neurosci Res 81, 363-373.
74. Jankowski, M., Hajjar, F., Kawas, S.A., Mukaddam-Daher, S., Hoffman, G., Mccann, S.M., and Gutkowska, J. (1998). Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A 95, 14558-14563.
75. Jankowski, M., Wang, D., Hajjar, F., Mukaddam-Daher, S., Mccann, S.M., and Gutkowska, J. (2000). Oxytocin and its receptors are synthesized in the rat vasculature. Proc Natl Acad Sci U S A 97, 6207-6211.
76. Jin, D., Liu, H.X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N.A., Yamada, K., Noda, M., Seike, T., Fujita, K., Takasawa, S., Yokoyama, S., Koizumi, K., Shiraishi, Y., Tanaka, S., Hashii, M., Yoshihara, T., Higashida, K., Islam, M.S., Yamada, N., Hayashi, K., Noguchi, N., Kato, I., Okamoto, H., Matsushima, A., Salmina, A., Munesue, T., Shimizu, N., Mochida, S., Asano, M., and Higashida, H. (2007). CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446, 41-45.
77. Jolley, S.N., Elmore, S., Barnard, K.E., and Carr, D.B. (2007). Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depression. Biol Res Nurs 8, 210-222.
78. Juckel, G., Manitz, M.P., Brune, M., Friebe, A., Heneka, M.T., and Wolf, R.J. (2011). Microglial activation in a neuroinflammational animal model of schizophrenia--a pilot study. Schizophr Res 131, 96-100.
79. Karelina, K., Stuller, K.A., Jarrett, B., Zhang, N., Wells, J., Norman, G.J., and Devries, A.C. (2011). Oxytocin mediates social neuroprotection after cerebral ischemia. Stroke 42, 3606-3611.
80. Kask, K., Gulinello, M., Backstrom, T., Geyer, M.A., and Sundstrom-Poromaa, I. (2008). Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 33, 2283-2290.
81. Kato, T., Mizoguchi, Y., Monji, A., Horikawa, H., Suzuki, S.O., Seki, Y., Iwaki, T., interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro. J Neurochem 106, 815-825.
82. Kato, T., Monji, A., Hashioka, S., and Kanba, S. (2007). Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 92, 108-115.
83. Kato, T.A., Monji, A., Mizoguchi, Y., Hashioka, S., Horikawa, H., Seki, Y., Kasai, M., Utsumi, H., and Kanba, S. (2011a). Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? Mini Rev Med Chem 11, 565-574.
84. Kato, T.A., Monji, A., Yasukawa, K., Mizoguchi, Y., Horikawa, H., Seki, Y., Hashioka, S., Han, Y.H., Kasai, M., Sonoda, N., Hirata, E., Maeda, Y., Inoguchi, T., Utsumi, H., and Kanba, S. (2011b). Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. Schizophr Res 129, 172-182.
85. Kato, T.A., Watabe, M., Tsuboi, S., Ishikawa, K., Hashiya, K., Monji, A., Utsumi, H., and Kanba, S. (2012). Minocycline Modulates Human Social Decision-Making: Possible Impact of Microglia on Personality-Oriented Social Behaviors. PLoS One 7, e40461.
86. Kato, T.A., Yamauchi, Y., Horikawa, H., Monji, A., Mizoguchi, Y., Seki, Y., Hayakawa, K., Utsumi, H., and Kanba, S. (2013). Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry. Curr Med Chem 20, 331-344
87. Kendler, K.S., Kessler, R.C., Walters, E.E., Maclean, C., Neale, M.C., Heath, A.C., and Eaves, L.J. (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152, 833-842.
88. Kettenmann, H., Hanisch, U.K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol Rev 91, 461-553.
89. Kiefer, R., Kieseier, B.C., Stoll, G., and Hartung, H.P. (2001). The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64, 109-127.
90. Kim, H.S., and Suh, Y.H. (2009). Minocycline and neurodegenerative diseases. Behav Brain Res 196, 168-179.
91. Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U., and Fehr, E. (2005). Oxytocin increases trust in humans. Nature 435, 673-676.
92. Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., Yuuki, N., Otsubo, T., Oshima, A., Kudo, K., Inoue, T., Kitaichi, Y., Shirakawa, O., Isogawa, K., Nagayama, H., Kamijima, K., Nanko, S., Kanba, S., Higuchi, T., and Mikuni, M. (2006). Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 31, 212-220.
93. Kurita, H., Maeshima, H., Kida, S., Matsuzaka, H., Shimano, T., Nakano, Y., Baba, H., Suzuki, T., and Arai, H. (2012). Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. J Affect Disord.
94. Laan, W., Smeets, H., De Wit, N.J., Kahn, R.S., Grobbee, D.E., and Burger, H. (2009). Glucocorticosteroids associated with a decreased risk of psychosis. J Clin Psychopharmacol 29, 288-290.
95. Landen, M., Nissbrandt, H., Allgulander, C., Sorvik, K., Ysander, C., and Eriksson, E. (2007). Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology 32, 153-161.
96. Lennartsson, A.K., and Jonsdottir, I.H. (2011). Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36, 1530-1539.
97. Lesch, K.P., Mayer, S., Disselkamp-Tietze, J., Hoh, A., Wiesmann, M., Osterheider, M., and Schulte, H.M. (1990). 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiatry 28, 620-628.
98. Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., and Kron, S. (2010). A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71, 138-149.
99. Lewis, K., Li, C., Perrin, M.H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T.M., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J., Sawchenko, P.E., and Vale, W.W. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98, 7570-7575.
100. Liaury, K., Miyaoka, T., Tsumori, T., Furuya, M., Wake, R., Ieda, M., Tsuchie, K., Taki, M., Ishihara, K., Tanra, A.J., and Horiguchi, J. (2012). Morphological features of microglial cells in the hippocampal dentate gyrus of Gunn rat: a possible schizophrenia animal model. J Neuroinflammation 9, 56.
101. Loram, L.C., Sholar, P.W., Taylor, F.R., Wiesler, J.L., Babb, J.A., Strand, K.A., Berkelhammer, D., Day, H.E., Maier, S.F., and Watkins, L.R. (2012). Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats. Psychoneuroendocrinology 37, 1688-1699.
102. Loram, L.C., Taylor, F.R., Strand, K.A., Frank, M.G., Sholar, P., Harrison, J.A., Maier, S.F., and Watkins, L.R. (2011). Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation. Brain Behav Immun 25, 1408-1415.
103. Lynn, D.J. (1995). Lithium in steroid-induced depression. Br J Psychiatry 166, 264.
104. Ma, Y., Jiang, J., Wang, L., Nie, H., Xia, W., Liu, J., and Ying, W. (2012). CD38 is a key enzyme for the survival of mouse microglial BV2 cells. Biochem Biophys Res Commun 418, 714-719.
105. Maes, M. (2011). An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry 35, 784-794.
106. Maes, M., Fisar, Z., Medina, M., Scapagnini, G., Nowak, G., and Berk, M. (2012). New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20, 127-150.
107. Maes, M., and Rief, W. (2012). Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res 196, 243-249.
108. Maezawa, I., and Jin, L.W. (2010). Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30, 5346-5356.
109. Maezawa, I., Swanberg, S., Harvey, D., Lasalle, J.M., and Jin, L.W. (2009). Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 29, 5051-5061.
110. Magiakou, M.A., Mastorakos, G., Rabin, D., Dubbert, B., Gold, P.W., and Chrousos, G.P. (1996). Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 81, 1912-1917.
111. Magos, A.L., Brewster, E., Singh, R., O'dowd, T., Brincat, M., and Studd, J.W. (1986). The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93, 1290-1296.
112. Mani, S., and Portillo, W. (2010). Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters. Front Neuroendocrinol 31, 157-171.
113. Mayo, L., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., Moutin, M.J., Lund, F.E., and Stein, R. (2008). Dual role of CD38 in microglial activation and activationinduced cell death. J Immunol 181, 92-103.
114. Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K.B., Putz, B., Bradley, B., Holsboer, F., Ressler, K.J., Muller-Myhsok, B., and Binder, E.B. (2011). Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68, 901-910.
115. Miller, G. (2005). Neuroscience. The dark side of glia. Science 308, 778-781.
116. Mittaud, P., Labourdette, G., Zingg, H., and Guenot-Di Scala, D. (2002). Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-beta and membrane components. Glia 37, 169-177.
117. Miyaoka, T. (2008). Clinical potential of minocycline for schizophrenia. CNS Neurol Disord Drug Targets 7, 376-381.
118. Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., Tsuchie, K., Taki, M., Ishihara, K., Araki, T., and Horiguchi, J. (2012). Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 37, 222-226.
119. Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., and Horiguchi, J. (2007). Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31, 304-307.
120. Moderscheim, T.A., Gorba, T., Pathipati, P., Kokay, I.C., Grattan, D.R., Williams, C.E., and Scheepens, A. (2007). Prolactin is involved in glial responses following a focal injury to the juvenile rat brain. Neuroscience 145, 963-973.
121. Monji, A., Kato, T., and Kanba, S. (2009). Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63, 257-265.
122. Monji, A., Kato, T.A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., and Kanba, S. (2011). Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry.
123. Mooradian, A.D., Morley, J.E., and Korenman, S.G. (1987). Biological actions of androgens. Endocr Rev 8, 1-28.
124. Moos, F., Freund-Mercier, M.J., Guerne, Y., Guerne, J.M., Stoeckel, M.E., and Richard, P. (1984). Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J Endocrinol 102, 63-72.
125. Morgan, J.T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E., and Everall, I.P. (2012). Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456, 72-81.
126. Morgan, J.T., Chana, G., Pardo, C.A., Achim, C., Semendeferi, K., Buckwalter, J., Courchesne, E., and Everall, I.P. (2010). Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68, 368-376.
127. Morrison, M.F., Kallan, M.J., Ten Have, T., Katz, I., Tweedy, K., and Battistini, M. (2004). Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55, 406-412.
128. Mosser, D.M., and Edwards, J.P. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969.
129. Munck, A., Guyre, P.M., and Holbrook, N.J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5, 25-44.
130. Munesue, T., Yokoyama, S., Nakamura, K., Anitha, A., Yamada, K., Hayashi, K., Asaka, T., Liu, H.X., Jin, D., Koizumi, K., Islam, M.S., Huang, J.J., Ma, W.J., Kim, U.H., Kim, S.J., Park, K., Kim, D., Kikuchi, M., Ono, Y., Nakatani, H., Suda, S., Miyachi, T., Hirai, H., Salmina, A., Pichugina, Y.A., Soumarokov, A.A., Takei, N., Mori, N., Tsujii, M., Sugiyama, T., Yagi, K., Yamagishi, M., Sasaki, T., Yamasue, H., Kato, N., Hashimoto, R., Taniike, M., Hayashi, Y., Hamada, J., Suzuki, S., Ooi, A., Noda, M., Kamiyama, Y., Kido, M.A., Lopatina, O., Hashii, M., Amina, S., Malavasi, F., Huang, E.J., Zhang, J., Shimizu, N., Yoshikawa, T., Matsushima, A., Minabe, Y., and Higashida, H. (2010). Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res 67, 181-191.
131. Munhoz, C.D., Sorrells, S.F., Caso, J.R., Scavone, C., and Sapolsky, R.M. (2010). Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J Neurosci 30, 13690-13698.
132. Nair, A., and Bonneau, R.H. (2006). Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 171, 72-85.
133. Neigh, G.N., Karelina, K., Glasper, E.R., Bowers, S.L., Zhang, N., Popovich, P.G., and Devries, A.C. (2009). Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke 40, 3601-3607.
134. Neufeld-Cohen, A., Tsoory, M.M., Evans, A.K., Getselter, D., Gil, S., Lowry, C.A., Vale, W.W., and Chen, A. (2010). A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci U S A 107, 19020-19025.
135. Neumann, I., Douglas, A.J., Pittman, Q.J., Russell, J.A., and Landgraf, R. (1996). Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events. J Neuroendocrinol 8, 227-233.
136. Neumann, I., Koehler, E., Landgraf, R., and Summy-Long, J. (1994). An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats. Endocrinology 134, 141-148.
137. Newport, D.J., Hostetter, A., Arnold, A., and Stowe, Z.N. (2002). The treatment of postpartum depression: minimizing infant exposures. J Clin Psychiatry 63 Suppl 7, 31-44.
138. Niwa, M., Jaaro-Peled, H., Tankou, S., Seshadri, S., Hikida, T., Matsumoto, Y., Cascella, N.G., Kano, S., Ozaki, N., Nabeshima, T., and Sawa, A. (2013). Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339, 335-339.
139. Nolen-Hoeksema, S. (1987). Sex differences in unipolar depression: evidence and theory. Psychol Bull 101, 259-282.
140. Nolten, W.E., Lindheimer, M.D., Rueckert, P.A., Oparil, S., and Ehrlich, E.N. (1980). Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51, 466-472.
141. Ochedalski, T., Subburaju, S., Wynn, P.C., and Aguilera, G. (2007). Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J Neuroendocrinol 19, 189-197.
142. Ock, J., Lee, H., Kim, S., Lee, W.H., Choi, D.K., Park, E.J., Kim, S.H., Kim, I.K., and Suk, K. (2006). Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem 98, 962-972.
143. Oki, Y., and Sasano, H. (2004). Localization and physiological roles of urocortin. Peptides 25, 1745-1749.
144. Oliveira-Pelegrin, G.R., Saia, R.S., Carnio, E.C., and Rocha, M.J. (2013). Oxytocin Affects Nitric Oxide and Cytokine Production by Sepsis-Sensitized Macrophages. Neuroimmunomodulation 20, 65-71.
145. Ostensen, M., Brucato, A., Carp, H., Chambers, C., Dolhain, R.J., Doria, A., Forger, F., Gordon, C., Hahn, S., Khamashta, M., Lockshin, M.D., Matucci-Cerinic, M., Meroni, P., Nelson, J.L., Parke, A., Petri, M., Raio, L., Ruiz-Irastorza, G., Silva, C.A., Tincani, A., Villiger, P.M., Wunder, D., and Cutolo, M. (2011). Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 50, 657-664.
146. Osuji, I.J., Vera-Bolanos, E., Carmody, T.J., and Brown, E.S. (2010). Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Res 178, 309-312.
147. Otte, C., Kellner, M., Arlt, J., Jahn, H., Holsboer, F., and Wiedemann, K. (2002). Prolactin but not ACTH increases during sodium lactate-induced panic attacks. Psychiatry Res 109, 201-205.
148. Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T.A., Guiducci, E., Dumas, L., Ragozzino, D., and Gross, C.T. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458.
149. Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I.M., and Ethell, D.W. (2010). Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol 10, 91.
150. Peeters, F., Nicholson, N.A., and Berkhof, J. (2003). Cortisol responses to daily events in major depressive disorder. Psychosom Med 65, 836-841.
151. Pelleymounter, M.A., Joppa, M., Ling, N., and Foster, A.C. (2004). Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III. Peptides 25, 659-666.
152. Petraglia, F., Sutton, S., Vale, W., and Plotsky, P. (1987). Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 120, 1083-1088.
153. Pittman, Q.J. (2011). A neuro-endocrine-immune symphony. J Neuroendocrinol 23, 1296-1297.
154. Polkowska, J., and Przekop, F. (1997). The effect of corticotropin-releasing factor (CRF) on the gonadotropin hormone releasing hormone (GnRH) hypothalamic neuronal system during preovulatory period in the ewe. Acta Neurobiol Exp (Wars) 57, 91-99.
155. Ponsonby, A.L., Lucas, R.M., Van Der Mei, I.A., Dear, K., Valery, P.C., Pender, M.P., Taylor, B.V., Kilpatrick, T.J., Coulthard, A., Chapman, C., Williams, D., Mcmichael, A.J., and Dwyer, T. (2012). Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology 78, 867-874.
156. Prinz, M., and Hanisch, U.K. (1999). Murine microglial cells produce and respond to interleukin-18. J Neurochem 72, 2215-2218.
157. Prossin, A.R., Koch, A.E., Campbell, P.L., Mcinnis, M.G., Zalcman, S.S., and Zubieta, J.K. (2011). Association of plasma interleukin-18 levels with emotion regulation and mu-opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry 69, 808-812.
158. Purba, J.S., Hoogendijk, W.J., Hofman, M.A., and Swaab, D.F. (1996). Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 53, 137-143.
159. Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C., Tilders, F.J., and Swaab, D.F. (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60, 436-444.
160. Ransohoff, R.M., and Stevens, B. (2011). Neuroscience. How many cell types does it take to wire a brain? Science 333, 1391-1392.
161. Reck, C., Stehle, E., Reinig, K., and Mundt, C. (2009). Maternity blues as a predictor of DSM-IV depression and anxiety disorders in the first three months postpartum. J Affect Disord 113, 77-87.
162. Roca, C.A., Schmidt, P.J., Smith, M.J., Danaceau, M.A., Murphy, D.L., and Rubinow, D.R. (2002). Effects of metergoline on symptoms in women with premenstrual dysphoric disorder. Am J Psychiatry 159, 1876-1881.
163. Ros-Bernal, F., Hunot, S., Herrero, M.T., Parnadeau, S., Corvol, J.C., Lu, L., Alvarez-Fischer, D., Carrillo-De Sauvage, M.A., Saurini, F., Coussieu, C., Kinugawa, K., Prigent, A., Hoglinger, G., Hamon, M., Tronche, F., Hirsch, E.C., and Vyas, S. (2011). Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A 108, 6632-6637.
164. Ross, H.E., and Young, L.J. (2009). Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol 30, 534-547.
165. Roy, A., Pickar, D., De Jong, J., Karoum, F., and Linnoila, M. (1988). Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch Gen Psychiatry 45, 849-857.
166. Rubinow, D.R., Hoban, M.C., Grover, G.N., Galloway, D.S., Roy-Byrne, P., Andersen, R., and Merriam, G.R. (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158, 5-11.
167. Saijo, K., Collier, J.G., Li, A.C., Katzenellenbogen, J.A., and Glass, C.K. (2011). An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584-595.
168. Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., Parolaro, D., Nishimori, K., Parenti, M., and Chini, B. (2011). Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol Psychiatry 69, 875-882.
169. Sarvari, M., Hrabovszky, E., Kallo, I., Solymosi, N., Toth, K., Liko, I., Szeles, J., Maho, S., Molnar, B., and Liposits, Z. (2011). Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats. J Neuroinflammation 8, 82.
170. Sassi, R.B., Nicoletti, M., Brambilla, P., Harenski, K., Mallinger, A.G., Frank, E., Kupfer, D.J., Keshavan, M.S., and Soares, J.C. (2001). Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 50, 271-280.
171. Sauer, C., Montag, C., Worner, C., Kirsch, P., and Reuter, M. (2012). Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: possible links to autism. Neuropsychopharmacology 37, 1474-1482.
172. Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., and Legros, J.J. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32, 407-410.
173. Schafer, D.P., Lehrman, E.K., Kautzman, A.G., Koyama, R., Mardinly, A.R., Yamasaki, R., Ransohoff, R.M., Greenberg, M.E., Barres, B.A., and Stevens, B. (2012). Microglia sculpt postnatal neural circuits in an activity and complementdependent manner. Neuron 74, 691-705.
174. Schmidt, P.J., Daly, R.C., Bloch, M., Smith, M.J., Danaceau, M.A., St Clair, L.S., Murphy, J.H., Haq, N., and Rubinow, D.R. (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62, 154-162.
175. Schmidt, P.J., Haq, N., and Rubinow, D.R. (2004). A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 161, 2238-2244.
176. Schmidt, P.J., Nieman, L.K., Grover, G.N., Muller, K.L., Merriam, G.R., and Rubinow, D.R. (1991). Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324, 1174-1179.
177. Schneider, T., and Popik, P. (2007). Increased depressive-like traits in an animal model of premenstrual irritability. Horm Behav 51, 142-148.
178. Schwarcz, R., Bruno, J.P., Muchowski, P.J., and Wu, H.Q. (2012). Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13, 465-477.
179. Schwarz, J.M., and Bilbo, S.D. (2012). Sex, glia, and development: interactions in health and disease. Horm Behav 62, 243-253.
180. Selye, H. (1950). Stress. Montreal: Acta Medical Publisher Inc.
181. Sher, L. (2012). Testosterone and suicidal behavior. Expert Rev Neurother 12, 257-259.
182. Sher, L., Grunebaum, M.F., Sullivan, G.M., Burke, A.K., Cooper, T.B., Mann, J.J., and Oquendo, M.A. (2012). Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res 46, 1267-1271.
183. Shirts, B.H., Wood, J., Yolken, R.H., and Nimgaonkar, V.L. (2008). Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity. Am J Med Genet B Neuropsychiatr Genet 147, 343-350.
184. Sierra, A., Gottfried-Blackmore, A., Milner, T.A., Mcewen, B.S., and Bulloch, K. (2008). Steroid hormone receptor expression and function in microglia. Glia 56, 659-674.
185. Smith, G.D., Seckl, J.R., Sheward, W.J., Bennie, J.G., Carroll, S.M., Dick, H., and Harmar, A.J. (1991). Effect of adrenalectomy and dexamethasone on neuropeptide content of dorsal root ganglia in the rat. Brain Res 564, 27-30.
186. Soares, C.N., Almeida, O.P., Joffe, H., and Cohen, L.S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58, 529-534.
187. Sorrells, S.F., Caso, J.R., Munhoz, C.D., and Sapolsky, R.M. (2009). The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 64, 33-39.
188. Stein, D.G. (2001). Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 24, 386-391.
189. Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.G., and Bogerts, B. (2008). Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42, 151-157.
190. Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.G., and Bogerts, B. (2006). Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112, 305-316.
191. Steiner, J., Walter, M., Gos, T., Guillemin, G.J., Bernstein, H.G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., Meyer Zu Schwabedissen, L., Bogerts, B., and Myint, A.M. (2011). Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8, 94.
192. Steiner, M. (2000). Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J Psychiatry Neurosci 25, 459-468.
193. Steiner, M., Dunn, E., and Born, L. (2003). Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74, 67-83.
194. Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., and Streiner, D. (1995). Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 332, 1529-1534.
195. Steinert, J.R., Robinson, S.W., Tong, H., Haustein, M.D., Kopp-Scheinpflug, C., and Forsythe, I.D. (2011). Nitric oxide is an activity-dependent regulator of target neuron intrinsic excitability. Neuron 71, 291-305.
196. Sugama, S., Fujita, M., Hashimoto, M., and Conti, B. (2007). Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 146, 1388-1399.
197. Sugama, S., Takenouchi, T., Fujita, M., Conti, B., and Hashimoto, M. (2009). Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 207, 24-31.
198. Sugama, S., Takenouchi, T., Fujita, M., Kitani, H., Conti, B., and Hashimoto, M. (2013). Corticosteroids limit microglial activation occurring during acute stress. Neuroscience 232C, 13-20.
199. Sugama, S., Wirz, S.A., Barr, A.M., Conti, B., Bartfai, T., and Shibasaki, T. (2004). Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Neuroscience 128, 451-458.
200. Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., Yoshihara, Y., Omata, K., Matsumoto, K., Tsuchiya, K.J., Iwata, Y., Tsujii, M., Sugiyama, T., and Mori, N. (2013). Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70, 49-58.
201. Szeto, A., Nation, D.A., Mendez, A.J., Dominguez-Bendala, J., Brooks, L.G., Schneiderman, N., and Mccabe, P.M. (2008). Oxytocin attenuates NADPHdependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 295, E1495-1501.
202. Takano, A., Arakawa, R., Ito, H., Tateno, A., Takahashi, H., Matsumoto, R., Okubo, Y., and Suhara, T. (2010). Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int J Neuropsychopharmacol 13, 943-950.
203. Tanaka, J., Fujita, H., Matsuda, S., Toku, K., Sakanaka, M., and Maeda, N. (1997). Glucocorticoid-and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia 20, 23-37.
204. Terao, T., Yoshimura, R., Shiratuchi, T., and Abe, K. (1997). Effects of lithium on steroid-induced depression. Biol Psychiatry 41, 1225-1226.
205. Tetreault, N.A., Hakeem, A.Y., Jiang, S., Williams, B.A., Allman, E., Wold, B.J., and Allman, J.M. (2012). Microglia in the cerebral cortex in autism. J Autism Dev Disord 42, 2569-2584.
206. Tokita, K., Fujita, Y., Yamaji, T., and Hashimoto, K. (2012). Depressive-like behavior in adrenocorticotropic hormone-treated rats blocked by memantine. Pharmacol Biochem Behav 102, 329-334.
207. Torner, L., Toschi, N., Pohlinger, A., Landgraf, R., and Neumann, I.D. (2001). Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J Neurosci 21, 3207-3214.
208. Tremblay, M.E., Stevens, B., Sierra, A., Wake, H., Bessis, A., and Nimmerjahn, A. (2011). The role of microglia in the healthy brain. J Neurosci 31, 16064-16069.
209. Tringali, G., Pozzoli, G., Vairano, M., Mores, N., Preziosi, P., and Navarra, P. (2005). Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. J Neuroimmunol 160, 61-67.
210. Tsigos, C., and Chrousos, G.P. (2002). Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53, 865-871.
211. Tsujimura, K., Abematsu, M., Kohyama, J., Namihira, M., and Nakashima, K. (2009). Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. Exp Neurol 219, 104-111.
212. Tynan, R.J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K.M., Pow, D.V., Day, T.A., and Walker, F.R. (2010). Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 24, 1058-1068.
213. Utari, A., Chonchaiya, W., Rivera, S.M., Schneider, A., Hagerman, R.J., Faradz, S.M., Ethell, I.M., and Nguyen, D.V. (2010). Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 115, 433-443.
214. Uvnas-Moberg, K., Bjokstrand, E., Hillegaart, V., and Ahlenius, S. (1999). Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl) 142, 95-101.
215. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397.
216. Van Berckel, B.N., Bossong, M.G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A.D., Cahn, W., Lammertsma, A.A., and Kahn, R.S. (2008). Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64, 820-822.
217. Van Wingen, G.A., Van Broekhoven, F., Verkes, R.J., Petersson, K.M., Backstrom, T., Buitelaar, J.K., and Fernandez, G. (2008). Progesterone selectively increases amygdala reactivity in women. Mol Psychiatry 13, 325-333.
218. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M.H., Lewis, K., Sutton, S., Chan, R., Turnbull, A.V., Lovejoy, D., Rivier, C., and Et Al. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropinreleasing factor. Nature 378, 287-292.
219. Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F., Brusadelli, A., Viviani, B., Ciana, P., and Maggi, A. (2001). Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21, 1809-1818.
220. Voskuhl, R.R., and Gold, S.M. (2012). Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 8, 255-263.
221. Wake, H., Moorhouse, A.J., Jinno, S., Kohsaka, S., and Nabekura, J. (2009). Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29, 3974-3980.
222. Walf, A.A., Paris, J.J., Rhodes, M.E., Simpkins, J.W., and Frye, C.A. (2011). Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues. Brain Res 1379, 119-136.
223. Wang, M.J., Lin, S.Z., Kuo, J.S., Huang, H.Y., Tzeng, S.F., Liao, C.H., Chen, D.C., and Chen, W.F. (2007). Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol 179, 6204-6214.
224. Wang, W., Ji, P., and Dow, K.E. (2003). Corticotropin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP kinase signalling pathways. J Neurochem 84, 189-195.
225. Wang, W., Ji, P., Riopelle, R.J., and Dow, K.E. (2002). Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia. J Neurochem 80, 287-294.
226. Watabe, M., Kato, T.A., Monji, A., Horikawa, H., and Kanba, S. (2012). Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction? Psychopharmacology (Berl) 220, 551-557.
227. Windle, R.J., Shanks, N., Lightman, S.L., and Ingram, C.D. (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138, 2829-2834.
228. Wolkowitz, O.M., Reus, V.I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., and Roberts, E. (1999). Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156, 646-649.
229. Wong, A.M., Rozovsky, I., Arimoto, J.M., Du, Y., Wei, M., Morgan, T.E., and Finch, C.E. (2009). Progesterone influence on neurite outgrowth involves microglia. Endocrinology 150, 324-332.
230. Woods, N.F., and Mitchell, E.S. (1996). Patterns of depressed mood in midlife women; observations from the Seattle Midlife Women's Health Study. Res Nurs Health 19, 111-123.
231. Xiu, M.H., Chen Da, C., Wang, D., Zhang, K., Dong, A., Tang, W., Zhang, F., Liu, L.J., Liu, J.H., Liu, H.B., Yang, F.D., Kosten, T.R., and Zhang, X.Y. (2012). Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology. J Psychiatr Res 46, 1093-1098.
232. Yang, Y., Hahm, E., Kim, Y., Kang, J., Lee, W., Han, I., Myung, P., Kang, H., Park, H., and Cho, D. (2005). Regulation of IL-18 expression by CRH in mouse microglial cells. Immunol Lett 98, 291-296.
233. Yin, D., Gao, W., Kearbey, J.D., Xu, H., Chung, K., He, Y., Marhefka, C.A., Veverka, K.A., Miller, D.D., and Dalton, J.T. (2003). Pharmacodynamics of selective androgen receptor modulators. J Pharmacol Exp Ther 304, 1334-1340.
234. Young, E.A., Midgley, A.R., Carlson, N.E., and Brown, M.B. (2000). Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 57, 1157-1162.
235. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., and Koistinaho, J. (1998). Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95, 15769-15774.
236. Yrjanheikki, J., Tikka, T., Keinanen, R., Goldsteins, G., Chan, P.H., and Koistinaho, J. (1999). A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96, 13496-13500.
237. Hashimoto, K. (2013). Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression. Prog Neurobiol 100, 15-29.
238. Ho, H.P., Olsson, M., Westberg, L., Melke, J., and Eriksson, E. (2001). The serotonin reuptake inhibitor fluoxetine reduces sex steroidrelated aggression in female rats: an animal model of premenstrual irritability? Neuropsychopharmacology 24, 502-510.
239. Schneider, T., and Popik, P. (2007). Increased depressive-like traits in an animal model of premenstrual irritability. Horm Behav 51, 142-148.